Healthy Skepticism Library item: 6651

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Sanofi Winthrop claims that Plaquenil “can help prevent the long-term damage of RA” and has a “low incidence of side effects”
MaLAM Australian News 1996 Feb; 4:(2):1

Abstract:

Sanofi Winthrop’s marketing of Plaquenil (hydroxychloroquiine) claims that it can prevent long-term damage due to rheumatoid arthritis and that it has a low incidence of side effects. MaLAM examines both of these claims in its monthly letter.

Keywords:
*analysis/Australia/developed countries/Plaquenil/hydroxychloroquine/Sanofi Winthrop/safety & risk information/ arthritis/MaLAM/Medical Lobby for Appropriate Marketing/EVALUATION OF PROMOTION: DRUG SAFETY/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPED COUNTRIES